Related Experiment Video
Updated: May 7, 2026

Measuring Psoriasis Severity at Home
Published on: March 1, 2024
Psoriasis and Cardiovascular Risk: Assessment by CUORE Project Risk Score in Italian Patients
Spyridoula Doukaki1, Valentina Caputo, Maria Rita Bongiorno
1Department of Dermatology, University of Palermo, Via del Vespro 131, 90123 Palermo, Italy.
Insights
Psoriasis patients have a significantly higher cardiovascular risk compared to those without the condition. Early identification and management of cardiovascular risk factors in psoriasis is crucial for prevention.
Area of Science:
- Dermatology
- Cardiology
- Epidemiology
Background:
- Psoriasis is a prevalent inflammatory skin condition with debated links to cardiovascular disease.
- Existing research indicates a potential increase in cardiovascular risk factors and diseases among psoriasis patients.
- This study investigates the association between psoriasis and cardiovascular risk.
Purpose of the Study:
- To assess the cardiovascular risk score in patients with psoriasis.
- To explore the relationship between cardiovascular risk and specific psoriasis features.
- To evaluate cardiovascular risk using the CUORE project risk score.
Main Methods:
- A case-control study involving 210 psoriasis outpatients and 111 controls with other skin conditions.
- Utilized the CUORE project risk score, designed for populations with low coronary heart disease rates.
- Compared cardiovascular risk scores between psoriasis patients and controls.
Main Results:
- Psoriasis patients exhibited a significantly higher CUORE project risk score than controls (6.80 ± 6.34 vs. 4.48 ± 4.38, P < 0.001).
- Psoriasis patients face an elevated risk of major cardiovascular events compared to controls.
- No significant correlation was found between cardiovascular risk and specific psoriasis characteristics.
Conclusions:
- Psoriasis is associated with increased cardiovascular risk.
- Routine screening for cardiovascular risk factors in psoriasis patients is recommended.
- Proactive lifestyle modifications and therapeutic interventions are warranted for psoriasis patients to mitigate cardiovascular risks.
Abstract:
Background. Psoriasis is a common inflammatory and immune-mediated skin disease. There is growing controversy as to whether cardiovascular risk is elevated in psoriasis. A number of studies suggest a high prevalence of cardiovascular risk factors as well as cardiovascular diseases in psoriasis patients. Objective. The objective of this study was to estimate cardiovascular risk score in psoriasis patients and the relation between cardiovascular risk and psoriasis features. Cardiovascular risk was assessed by CUORE project risk score built within the longitudinal study of the Italian CUORE project and suited to populations with a low rate of coronary heart disease. Results. A case-control study in 210 psoriasis outpatients and 111 controls with skin diseases other than psoriasis was performed. CUORE project risk score was higher in patients than controls (6.80 ± 6.34 versus 4.48 ± 4.38, P < 0.001). Compared to controls, psoriasis patients have higher risk of developing major cardiovascular events. Cardiovascular risk was not related to psoriasis characteristics. Conclusion. Increased focus on identifying cardiovascular risk factors and initiation of preventive lifestyle changes or therapeutic interventions in patients with psoriasis is warranted.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Relative Risk
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease IV: Preventive Measures
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
